Literature DB >> 12112211

Friedreich's ataxia with chorea and myoclonus caused by a compound heterozygosity for a novel deletion and the trinucleotide GAA expansion.

Danqing Zhu1, Christopher Burke, Anthony Leslie, Garth A Nicholson.   

Abstract

Friedreich's ataxia (FRDA) is the most common hereditary ataxia, affecting about 1 in 50,000 individuals. It is caused by mutations in the frataxin gene; 98% of cases have homozygous expansions of a GAA trinucleotide in intron 1 of the frataxin gene. The remaining 2% of patients are compound heterozygotes, who have a GAA repeat expansion in one allele and a point mutation in the other allele. FRDA patients with point mutation have been suggested to have atypical clinical features. We present a case of compound heterozygotes in a FRDA patient who has a deletion of one T in the start codon (ATG) of the frataxin gene and a GAA repeat expansion in the other allele. The patient presented with chorea and subsequently developed FRDA symptoms. The disease in this case is the result of both a failure of initiation of translation and the effect of the expansion. This novel mutation extends the range of point mutations seen in FRDA patients, and also broadens the spectrum of FRDA genotype associated with chorea. Copyright 2002 Movement Disorder Society

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12112211     DOI: 10.1002/mds.10175

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  15 in total

1.  Heterogeneity and frequency of movement disorders in juvenile and adult-onset Niemann-Pick C disease.

Authors:  Mathieu Anheim; Ouhaïd Lagha-Boukbiza; Marie-Céline Fleury-Lesaunier; Maria-Paola Valenti-Hirsch; Edouard Hirsch; Hélène Gervais-Bernard; Emmanuel Broussolle; Stéphane Thobois; Marie T Vanier; Philippe Latour; Christine Tranchant
Journal:  J Neurol       Date:  2013-11-01       Impact factor: 4.849

Review 2.  Ataxia.

Authors:  Umar Akbar; Tetsuo Ashizawa
Journal:  Neurol Clin       Date:  2015-02       Impact factor: 3.806

3.  Heart and Nervous System Pathology in Compound Heterozygous Friedreich Ataxia.

Authors:  Alyssa B Becker; Jiang Qian; Benjamin B Gelman; Michele Yang; Peter Bauer; Arnulf H Koeppen
Journal:  J Neuropathol Exp Neurol       Date:  2017-08-01       Impact factor: 3.685

Review 4.  Differential diagnosis of chorea.

Authors:  Ruth H Walker
Journal:  Curr Neurol Neurosci Rep       Date:  2011-08       Impact factor: 5.081

Review 5.  Friedreich ataxia: molecular mechanisms, redox considerations, and therapeutic opportunities.

Authors:  Renata Santos; Sophie Lefevre; Dominika Sliwa; Alexandra Seguin; Jean-Michel Camadro; Emmanuel Lesuisse
Journal:  Antioxid Redox Signal       Date:  2010-09-01       Impact factor: 8.401

6.  Frataxin gene point mutations in Italian Friedreich ataxia patients.

Authors:  Cinzia Gellera; Barbara Castellotti; Caterina Mariotti; Rossana Mineri; Viviana Seveso; Stefano Didonato; Franco Taroni
Journal:  Neurogenetics       Date:  2007-08-17       Impact factor: 2.660

Review 7.  Recent advances in genetics of chorea.

Authors:  Niccolò E Mencacci; Miryam Carecchio
Journal:  Curr Opin Neurol       Date:  2016-08       Impact factor: 5.710

8.  The differential diagnosis of Huntington's disease-like syndromes: 'red flags' for the clinician.

Authors:  Davide Martino; Maria Stamelou; Kailash P Bhatia
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-09-19       Impact factor: 10.154

Review 9.  Movement Disorders in Genetic Pediatric Ataxias.

Authors:  Simone Gana; Enza Maria Valente
Journal:  Mov Disord Clin Pract       Date:  2020-04-06

10.  Frataxin levels in peripheral tissue in Friedreich ataxia.

Authors:  Michael Lazaropoulos; Yina Dong; Elisia Clark; Nathaniel R Greeley; Lauren A Seyer; Karlla W Brigatti; Carlton Christie; Susan L Perlman; George R Wilmot; Christoper M Gomez; Katherine D Mathews; Grace Yoon; Theresa Zesiewicz; Chad Hoyle; Sub H Subramony; Alicia F Brocht; Jennifer M Farmer; Robert B Wilson; Eric C Deutsch; David R Lynch
Journal:  Ann Clin Transl Neurol       Date:  2015-07-01       Impact factor: 4.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.